Age-related clinical differences in children with Mycoplasma pneumoniae infection

Yuka Kuroda1, Hiroyuki Iijima2, Kensuke Shoji3

  • 1Department of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan; Center for Postgraduate Education and Training, National Center for Child Health and Development, Tokyo, Japan.

Insights

Mycoplasma pneumoniae causes pneumonia in children. Younger children with this infection experienced lower oxygen levels and more hospitalizations, indicating a higher risk of hypoxemia.

Area of Science:

  • Pediatric Infectious Diseases
  • Respiratory Medicine
  • Microbiology

Background:

  • Mycoplasma pneumoniae is a frequent cause of community-acquired pneumonia in school-aged children.
  • Clinical presentation of M. pneumoniae in younger children (<5 years) is not well-understood.

Purpose of the Study:

  • To characterize and compare the clinical features of M. pneumoniae infection in younger versus older pediatric patients.
  • To assess the risk of hypoxemia and hospitalization in different age groups.

Main Methods:

  • Retrospective cohort study of pediatric patients (<18 years) with isolated M. pneumoniae.
  • Exclusion of patients with co-infections or underlying conditions.
  • Comparison of clinical characteristics between younger (0-5 years) and older (6-17 years) children.

Main Results:

  • Younger children presented with significantly lower oxygen saturation.
  • Younger children required oxygen supplementation more frequently and had higher hospitalization rates.
  • Fever, cough, pneumonia rates, and laboratory findings were similar between age groups.

Conclusions:

  • M. pneumoniae infection in young children is associated with a higher risk of hypoxemia.
  • Despite similar clinical symptoms, younger children face increased severity and need for hospitalization.
  • Further research into age-specific management of M. pneumoniae is warranted.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410